Using a continuous glucose monitor to lose weight is an increasingly popular approach, with wearable CGM technology now accessible to people without diabetes seeking to better understand how food, activity, and lifestyle affect their blood sugar. Originally developed to help people with diabetes manage insulin dosing, devices such as the FreeStyle Libre and Dexcom G7 now feature in commercial wellness programmes promising personalised dietary insight. This guide explains how CGMs work, what the data can realistically tell you, how to use it safely alongside a healthy diet, and when to seek advice from a GP or registered dietitian.

What Is a Continuous Glucose Monitor and How Does It Work?

A CGM is a wearable medical device that measures interstitial glucose every one to five minutes; UK devices such as the FreeStyle Libre and Dexcom G7 are regulated by the MHRA and were originally developed for diabetes management.

A continuous glucose monitor (CGM) is a small wearable medical device that measures glucose levels in the interstitial fluid beneath the skin, typically every one to five minutes throughout the day and night. Unlike traditional finger-prick blood glucose tests, a CGM provides a continuous stream of data, allowing users to observe how their glucose levels rise and fall in real time.

There are two main types of CGM used in the UK:

• Real-time CGM (rtCGM): Transmits glucose readings continuously to a smartphone app or receiver and can trigger alarms for high or low readings. The Dexcom G7 is a widely used rtCGM in the UK.

• Intermittently scanned CGM (isCGM), also called flash glucose monitoring: Requires the user to scan the sensor to obtain a reading. The FreeStyle Libre range (Abbott) is the most common example, though the newer Libre 3 now also offers real-time transmission.

Both the Dexcom G7 and FreeStyle Libre range carry UKCA or CE marking and are regulated as medical devices by the Medicines and Healthcare products Regulatory Agency (MHRA). These devices were originally developed for people living with diabetes to help manage insulin dosing and reduce the risk of hypoglycaemia. Their use has since expanded into broader health and wellness contexts, including weight management.

Approved wear sites vary by device. For example, the FreeStyle Libre is licensed for the back of the upper arm only, whilst the Dexcom G7 has its own specified sites. Always follow the manufacturer's Instructions for Use (IFU) for your specific device.

CGMs measure interstitial glucose, not blood glucose directly. There is typically a lag of around five to fifteen minutes between blood glucose changes and interstitial readings. During periods of rapid glucose change — such as during a hypoglycaemic episode — this lag can be clinically relevant. If your symptoms do not match your CGM reading, always confirm with a finger-prick capillary blood glucose test.

Other important safety points to be aware of:

• Skin reactions: Adhesive allergy or skin irritation at the sensor site is relatively common. If you experience persistent redness, itching, or rash, remove the sensor and seek advice from a healthcare professional.

• Substance interferences: High-dose vitamin C (ascorbic acid) supplements can falsely elevate readings on some FreeStyle Libre models. Check the IFU for your device for a full list of known interferences.

• Compression lows: Lying on the sensor during sleep can produce falsely low readings. Reposition and rescan or check with a finger-prick if in doubt.

CGMs do not diagnose diabetes or any other condition. They are tools for generating personal health data that can inform lifestyle decisions when used appropriately. If you suspect a problem with your device, you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

How CGM Data Can Support Weight Management Goals

CGM data can help identify personal postprandial glucose patterns that may influence appetite and dietary adherence, but there is no NICE guidance recommending CGM specifically for weight loss in people without diabetes.

There is a recognised relationship between postprandial blood glucose patterns and appetite regulation, though the strength of this link in people without diabetes is still being studied. Large rises in blood glucose followed by rapid falls may contribute to hunger signals and cravings for high-carbohydrate foods in some individuals, though this is not uniformly established and individual responses vary considerably. By providing real-time visibility of these patterns, a CGM may help some people understand how their body responds to specific foods, meal timings, and lifestyle factors such as sleep and stress.

Using a CGM for weight management is not about achieving a specific glucose number, but rather about observing the amplitude and duration of glucose excursions over the course of the day. A more stable glucose profile is associated with improved satiety and more consistent energy levels in some research, and may support adherence to a calorie-controlled diet — though the evidence in non-diabetic populations is still emerging. Studies such as the PREDICT programme have highlighted substantial inter-individual variability in postprandial glucose responses to identical foods, suggesting that personalised dietary guidance may have value, but large-scale randomised controlled trial evidence specifically linking CGM use to weight loss in people without diabetes remains limited.

There is no NICE guidance recommending CGM use specifically for weight loss in people without diabetes. CGMs should be viewed as a supportive tool rather than a standalone weight loss intervention. Commercial programmes that incorporate CGM data (such as Zoe) are not NHS-endorsed, and independent peer-reviewed evidence for their weight loss outcomes is limited. They work best when combined with broader lifestyle changes — including a balanced diet, regular physical activity, adequate sleep, and stress management — all of which independently influence glucose metabolism and body weight.

Understanding Your Glucose Readings and Food Responses

Different foods produce highly variable glucose responses between individuals; informal wellness targets for postprandial rises are not clinically defined thresholds and are not endorsed by NICE or NHS guidelines.

When you begin using a CGM, you will quickly notice that different foods produce very different glucose responses — even within the same food category. For example, white rice may cause a sharp rise in one individual, whilst another person eating the same portion experiences a much more modest increase. This variability is influenced by factors including gut microbiome composition, insulin sensitivity, meal timing, physical activity levels, and the order in which foods are eaten during a meal. Research such as the PREDICT studies has demonstrated that these inter-individual differences are substantial and not reliably predicted by standard glycaemic index values alone.

Some wellness-focused CGM programmes use informal heuristics — for example, aiming for a postprandial rise of less than 1.7–2.0 mmol/L above the pre-meal baseline. It is important to understand that these are not clinically defined targets and are not endorsed by NICE or NHS guidelines for people without diabetes. They should not be treated as medical thresholds.

For context, in clinical diagnostics, a two-hour plasma glucose of 11.1 mmol/L or above is used as a threshold for diagnosing diabetes — but CGM interstitial readings are not equivalent to plasma glucose and cannot be used to diagnose diabetes or prediabetes. Repeated patterns of concern should always be followed up with a GP and confirmed with laboratory blood tests (such as HbA1c or fasting plasma glucose).

Foods that tend to produce larger glucose excursions in many people include:

• Refined carbohydrates: white bread, sugary breakfast cereals, pastries, fizzy drinks, and fruit juice

• Large portions of fast-digesting starchy foods eaten in isolation, such as white rice or mashed potato

• Sugary snacks and confectionery

In contrast, meals that combine protein, healthy fats, fibre, and complex carbohydrates tend to blunt the glucose response and sustain satiety for longer. Practical strategies that CGM data often visually reinforces include eating vegetables before carbohydrates, taking a short walk after meals, and avoiding large meals late at night. Seeing the direct impact of these behaviours on your own glucose trace can be a useful motivational tool, helping to build sustainable dietary habits. However, it is important to assess repeated patterns over days and weeks rather than reacting to individual readings, which can be affected by sensor lag, compression, or other variables.

Practical Steps for Using a CGM Alongside a Healthy Diet

Wearing a CGM for two to four weeks before changing your diet helps establish a personal baseline; combining food journalling, post-meal movement, and attention to sleep produces the most actionable insights.

To get the most from a CGM for weight management, it helps to approach the process systematically rather than reacting to individual readings in isolation. As a practical starting point, consider wearing the sensor for at least two to four weeks before making significant dietary changes — this allows you to identify your personal glucose patterns, including morning fasting levels, responses to habitual meals, and the impact of stress or poor sleep. This is a pragmatic suggestion rather than a formally evidence-based rule.

Once you have a baseline, consider the following practical steps:

• Food journalling alongside CGM data: Log your meals, portion sizes, and eating times in parallel with your glucose readings. Most CGM apps allow you to add meal notes directly, making it easier to identify which foods are associated with larger excursions.

• Experiment with meal composition: Try swapping refined carbohydrates for wholegrains, adding a source of protein or healthy fat to carbohydrate-rich meals, and observing the effect on your glucose trace.

• Incorporate post-meal movement: Even a 10–15 minute walk after eating has been shown in peer-reviewed research to meaningfully reduce postprandial glucose excursions. Your CGM will often reflect this benefit visually.

• Monitor sleep and stress: Poor sleep and elevated cortisol can raise fasting glucose levels. If you notice consistently elevated morning readings, consider lifestyle factors beyond diet.

• Follow your device's Instructions for Use: Adhere to the recommended sensor wear and change intervals, use alerts appropriately (for rtCGM devices), and be aware of known interferences specific to your device.

Safety reminders during use:

• If a reading does not match how you feel — particularly if you have symptoms of low blood glucose such as shakiness, sweating, or dizziness — always confirm with a finger-prick capillary test.

• Be aware of compression lows (falsely low readings caused by lying on the sensor) and substance interferences (e.g., high-dose vitamin C with some Libre models).

• Report any suspected device problems or adverse reactions via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk).

Avoid the temptation to optimise every reading obsessively. The goal is to identify broad, repeatable patterns that can guide sustainable dietary choices. If you find that monitoring your glucose levels is causing anxiety or disordered eating behaviours, pause use and seek guidance from a healthcare professional.

Who Can Access a CGM on the NHS and What Are the Costs?

NHS CGM access is limited to people with type 1 diabetes, insulin-treated type 2 diabetes, and certain pregnancy indications; people without diabetes must purchase sensors privately from a UKCA- or CE-marked device.

In the UK, CGM and flash glucose monitoring devices are available on the NHS, but access is currently restricted to specific clinical groups defined by NICE guidance:

• Adults with type 1 diabetes (NICE NG17): CGM or flash monitoring should be offered to all adults with type 1 diabetes.

• Children and young people with type 1 diabetes (NICE NG18): CGM or flash monitoring should be offered to all children and young people with type 1 diabetes.

• Adults with type 2 diabetes on insulin (NICE NG28): CGM or flash monitoring may be offered or considered for adults with type 2 diabetes who use insulin and meet specific clinical criteria.

• Diabetes in pregnancy (NICE NG3): Real-time CGM should be offered routinely to pregnant women with type 1 diabetes. For those with type 2 diabetes or gestational diabetes, CGM may be considered in certain circumstances — refer to NG3 for the specific criteria.

• People at high risk of hypoglycaemia may also be considered under relevant guidance.

For people without diabetes who wish to use a CGM for weight management or general wellness, NHS funding is not currently available. Costs must be met privately. Sensor prices vary and change over time; as a guide, FreeStyle Libre sensors typically last 14 days, whilst Dexcom G7 sensors last approximately 10 days. For current UK pricing, check the manufacturer's website (Abbott UK for FreeStyle Libre; Dexcom UK for the G7) or a registered UK pharmacy, as retail prices fluctuate.

Several private GP services and dietetic clinics in the UK now offer CGM-guided nutrition programmes, which may be appropriate for individuals with a clinical need — such as prediabetes, polycystic ovary syndrome (PCOS), or metabolic syndrome — who fall outside current NHS criteria.

If you are considering purchasing a CGM privately, ensure the device carries UKCA or CE marking as a medical device and purchase from a reputable UK supplier or registered pharmacy. The MHRA maintains oversight of medical devices in the UK. Commercial wellness programmes that incorporate CGM data are not NHS-endorsed; if you are considering one, seek independent clinical advice to help interpret your data safely.

When to Seek Advice From a GP or Dietitian

Speak to your GP before starting if you have untested blood sugar, take insulin or sulfonylureas, or have a history of eating disorders; seek urgent advice if fasting readings consistently exceed 7.0 mmol/L or symptoms of hypoglycaemia occur.

Whilst CGMs are generally safe for use in healthy adults, there are several circumstances in which it is important to seek professional guidance before or during use.

Before starting, speak with your GP if you:

• Have not previously been tested for diabetes or prediabetes — a fasting plasma glucose test or HbA1c measurement provides important context for interpreting CGM readings and may identify an underlying condition requiring medical management.

• Are pregnant, or planning to become pregnant.

• Take insulin, sulfonylureas, or other medicines that can cause hypoglycaemia — CGM use in these circumstances should be guided by your clinical team.

• Have a history of an eating disorder or significant anxiety around food.

• Have a skin condition or known adhesive allergy that may be aggravated by sensor wear.

During use, contact your GP if your CGM consistently shows patterns such as:

• Fasting readings above 7.0 mmol/L on multiple occasions

• Readings above 11.1 mmol/L regularly after meals

• Unexplained episodes of low glucose (readings below 3.9 mmol/L), particularly if accompanied by symptoms such as dizziness, sweating, shakiness, or confusion

It is essential to understand that CGM interstitial readings are not diagnostic. They cannot be used to diagnose diabetes or prediabetes. If your readings are consistently in a concerning range, your GP will arrange confirmatory laboratory tests — typically HbA1c and/or fasting plasma glucose — to assess whether further investigation or treatment is needed.

Seek urgent medical attention if you experience symptoms of severe hypoglycaemia (such as confusion, loss of consciousness, or seizure), or if you have classic symptoms of undiagnosed diabetes — including excessive thirst, frequent urination, unexplained weight loss, or recurrent infections — regardless of your CGM readings.

A registered dietitian can be an invaluable partner when using CGM data for weight management. They can help you interpret your glucose patterns in the context of your overall dietary intake, identify nutritional gaps, and develop a personalised eating plan that is both evidence-based and sustainable. Dietitians registered with the Health and Care Professions Council (HCPC) can be accessed via NHS referral or privately — you can verify registration at hcpc-uk.org.

Finally, if monitoring your glucose levels is contributing to anxiety, food fear, or obsessive dietary behaviours, discuss this with your GP or a mental health professional. CGMs are a tool to support informed decision-making — not a measure of personal worth or dietary perfection. Used thoughtfully and with appropriate support, they can be a genuinely useful addition to a broader, balanced approach to weight management.

Frequently Asked Questions